|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.95 USD | -1.88% |
|
+1.95% | -11.65% |
| 29/06 | AtriCure, Inc.(NasdaqGM:ATRC) added to Russell 2000 Defensive Index | CI |
| 29/06 | AtriCure, Inc.(NasdaqGM:ATRC) added to Russell 2000 Growth-Defensive Index | CI |
Company Valuation: AtriCure, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 3,194 | 2,064 | 1,692 | 1,490 | 1,967 | 1,770 | - | - |
| Change | - | -35.37% | -18.05% | -11.92% | 32.01% | -10.01% | - | - |
| Enterprise Value (EV) 1 | 3,210 | 2,063 | 1,623 | 1,441 | 1,873 | 1,614 | 1,538 | 1,432 |
| Change | - | -35.73% | -21.32% | -11.21% | 29.97% | -13.82% | -4.73% | -6.86% |
| P/E | 63.8x | -43.5x | -54.1x | -32.2x | -165x | 762x | 103x | 59.2x |
| PBR | 6.61x | 4.52x | 3.55x | 3.24x | 4x | 3.12x | 2.8x | 2.47x |
| PEG | - | 0x | 1.5x | -0.7x | 2.2x | -6x | 0x | 0.8x |
| Capitalization / Revenue | 11.6x | 6.25x | 4.24x | 3.2x | 3.68x | 2.93x | 2.61x | 2.32x |
| EV / Revenue | 11.7x | 6.24x | 4.06x | 3.1x | 3.5x | 2.67x | 2.27x | 1.88x |
| EV / EBITDA | -366x | -943x | 83.5x | 46.3x | 30.3x | 20x | 15.9x | 12.2x |
| EV / EBIT | -67.9x | -48.3x | -60.8x | -36x | -198x | 281x | 74.7x | 39.2x |
| EV / FCF | -136x | -52.9x | -216x | 1,934x | 38.8x | 29.9x | 37.5x | - |
| FCF Yield | -0.73% | -1.89% | -0.46% | 0.05% | 2.58% | 3.34% | 2.66% | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.09 | -1.02 | -0.66 | -0.95 | -0.24 | 0.0459 | 0.34 | 0.5903 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 274.3 | 330.4 | 399.2 | 465.3 | 534.5 | 604.9 | 678.5 | 763.4 |
| EBITDA 1 | -8.776 | -2.188 | 19.45 | 31.12 | 61.77 | 80.68 | 96.99 | 117.2 |
| EBIT 1 | -47.3 | -42.67 | -26.68 | -40.01 | -9.447 | 5.745 | 20.58 | 36.53 |
| Net income 1 | 50.2 | -46.47 | -34.85 | -44.7 | -11.45 | 2.565 | 16.96 | 29.93 |
| Net Debt 1 | 16.09 | -1.265 | -68.63 | -49 | -94.05 | -156 | -232.3 | -337.7 |
| Reference price 2 | 69.53 | 44.38 | 35.69 | 30.56 | 39.56 | 34.95 | 34.95 | 34.95 |
| Nbr of stocks (in thousands) | 45,932 | 46,508 | 47,395 | 48,753 | 49,717 | 50,641 | - | - |
| Announcement Date | 15/02/22 | 21/02/23 | 15/02/24 | 12/02/25 | 17/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 762.1x | 2.67x | 20x | - | 176.99Cr | |
| 27.38x | 3.95x | 15.2x | 2.57% | 18TCr | |
| 18.88x | 3.31x | 11.62x | 3.57% | 11TCr | |
| 17.13x | 0.19x | 12.1x | 0.77% | 5.99TCr | |
| 31.81x | 7.73x | 20.21x | 1.26% | 5.2TCr | |
| 39.41x | 3.13x | 10.67x | 2.43% | 4.36TCr | |
| 38.15x | 1.39x | 12.22x | 0.26% | 3.36TCr | |
| 31.31x | 5.58x | 17.8x | -.--% | 2.96TCr | |
| 42.57x | 7.44x | 26.86x | 0.24% | 2.53TCr | |
| 23.96x | 3.5x | 12.59x | 1.21% | 2.12TCr | |
| Average | 103.27x | 3.89x | 15.93x | 1.37% | 5.49TCr | |
| Weighted average by Cap. | 29.79x | 3.78x | 14.69x | 1.99% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ATRC Stock
- Valuation AtriCure, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
